Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity
about
How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?Intranasal immunization with nontypeable Haemophilus influenzae outer membrane vesicles induces cross-protective immunity in miceTargeting imperfect vaccines against drug-resistance determinants: a strategy for countering the rise of drug resistanceRandomized controlled study of the safety and immunogenicity of pneumococcal vaccine formulations containing PhtD and detoxified pneumolysin with alum or adjuvant system AS02V in elderly adultsDevelopment of Streptococcus pneumoniae Vaccines Using Live VectorsCurrent concepts in host-microbe interaction leading to pneumococcal pneumoniaVaccination against Streptococcus pneumoniae using truncated derivatives of polyhistidine triad protein DDynamics of lung defense in pneumonia: resistance, resilience, and remodeling.C-reactive protein protects mice against pneumococcal infection via both phosphocholine-dependent and phosphocholine-independent mechanisms.A strain-independent method to induce progressive and lethal pneumococcal pneumonia in neutropenic micePrevention and Control of Childhood Pneumonia and DiarrheaHIV-induced immunosuppression is associated with colonization of the proximal gut by environmental bacteria.T(H)17-Mediated Protection against Pneumococcal Carriage by a Whole-Cell Vaccine Is Dependent on Toll-Like Receptor 2 and Surface Lipoproteins.Controlled inflammatory responses in the lungs are associated with protection elicited by a pneumococcal surface protein A-based vaccine against a lethal respiratory challenge with Streptococcus pneumoniae in mice.A novel flow cytometry-based assay for the quantification of antibody-dependent pneumococcal agglutination.The phosphocholine-binding pocket on C-reactive protein is necessary for initial protection of mice against pneumococcal infectionRole of pore-forming toxins in neonatal sepsisNovel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilmsHost defenses against bacterial lower respiratory tract infection.Otitis-Prone Children Produce Functional Antibodies to Pneumolysin and Pneumococcal Polysaccharides.Toll-like receptor 2-dependent protection against pneumococcal carriage by immunization with lipidated pneumococcal proteins.Glycoconjugate vaccines.Th17 cell based vaccines in mucosal immunity.Current status and perspectives on protein-based pneumococcal vaccines.Helper T-cell type 17 cytokines and immunity in the lungSublingual flagellin protects against acute pneumococcal pneumonia in a TLR5-dependent and NLRC4-independent fashion.Pneumococcal Capsular Polysaccharide Immunity in the Elderly.Th17-mediated cross protection against pneumococcal carriage by vaccination with a variable antigen.Activation of memory Th17 cells by domain 4 pneumolysin in human nasopharynx-associated lymphoid tissue and its association with pneumococcal carriage.Exploring the role of competition induced by non-vaccine serotypes for herd protection following pneumococcal vaccination.Streptococcus pneumoniae Attenuated Strain SPY1 with an Artificial Mineral Shell Induces Humoral and Th17 Cellular Immunity and Protects Mice against Pneumococcal Infection.Recent approaches in whole cell pneumococcal vaccine development: a review study.
P2860
Q26748155-02F35B49-E641-413C-A031-6FEC8407979BQ28482083-EE49C18F-9FA6-4A17-9547-0201C5851BF9Q28534880-41C6AC0D-D67D-4AF5-A06E-4C7648CF2ACBQ33601853-83C7FB42-1993-4C76-9B87-8BF72F17488BQ34316015-750053A3-2C4D-4C17-8200-3917227D8958Q34540722-8887346C-1B0B-4E7E-9322-78D2282DC18AQ35036855-17077C06-DEA1-4651-B637-D7A31111D2D8Q35196768-BBDA4E01-32E0-4EF1-BA5F-EEB005A21BB3Q35439657-B8338766-E1E0-440C-A4BF-700FAD8ED662Q35761235-D1CB927C-C5CA-487C-90AE-0D75DB53B452Q35854529-1F005295-8C96-4244-8565-FB50BA3822CCQ35885861-BBD94090-709B-4BE5-90B3-6E0C92C1C35CQ35902005-B8198A4A-9D5E-438E-9B58-79FC6A5AE3D0Q36191618-4A664D70-1A6A-4214-838E-38CFB31C65BBQ36306162-2FC32085-2861-4E52-908C-A5E6B78BD6D8Q36466829-5F772C42-5B79-4BEC-940D-C4A98D2F8BC4Q36848321-AF40E3F1-F482-43FD-9582-342C235725BDQ37174555-44724E7D-6817-4875-BF84-B625900FB979Q37677020-48671756-1CE0-4533-B8F7-216022FCE1C6Q37683735-DA4C76AB-8E8F-4A12-BDDB-7E63C6A109D1Q37713348-EBEF24F9-49CE-496E-80D6-18A093C3A789Q38044755-E1B6CD9E-70C1-4966-8DDE-3B4854ECC035Q38106558-CA74D597-C7C6-46F8-AD57-5E61AC66FA42Q38124921-95E7D003-9539-42BA-9D3A-4E61DDFC80F0Q38294540-30E1EB3E-CB1C-4B9A-8D9B-C9BDB8CD522FQ38829301-543B076B-96AD-4D66-A7C2-E8947CD69DB9Q38861144-CB15BF44-03B7-448C-AFA8-06F0390171DEQ40119286-3F39498C-BB13-4E2B-81C4-7C66E5715731Q43519933-E03ED21C-66CE-44F6-9A87-D64A40D9B271Q47115918-732523F9-1580-40D1-8CFC-B4F424344E3DQ48521617-6D018EB3-3FF3-43C9-9D72-1F52A70E9D80Q50305151-8186B19E-D04E-4D85-ACC0-466CE24B32F7
P2860
Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Serotype-independent pneumococ ...... ar as well as humoral immunity
@ast
Serotype-independent pneumococ ...... ar as well as humoral immunity
@en
type
label
Serotype-independent pneumococ ...... ar as well as humoral immunity
@ast
Serotype-independent pneumococ ...... ar as well as humoral immunity
@en
prefLabel
Serotype-independent pneumococ ...... ar as well as humoral immunity
@ast
Serotype-independent pneumococ ...... ar as well as humoral immunity
@en
P2860
P356
P1476
Serotype-independent pneumococ ...... ar as well as humoral immunity
@en
P2093
Porter W Anderson
Richard Malley
P2860
P304
P356
10.1073/PNAS.1121383109
P407
P577
2012-02-02T00:00:00Z